LGND

NEUTRALAnalyst

Ligand Pharmaceuticals Incorpor

2026-07-24

Price

$300.53

-0.54%

This is the 2026-07-24 snapshot — the signals and analysis for LGND as of this single trading day.

View full LGND research hub →

Score2.0Noise

Signals2/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume0.6xvs 20d avg

Analysis

LGND is exhibiting High-Conviction Price Discovery, driven by a concentrated wave of Wall Street upgrades and price target hikes up to $345 ahead of its August 6 earnings. Despite a CAUTION macro regime dominated by geopolitical and tariff anxieties, the stock boasts a +6.9% relative strength versus the SPY, confirming institutional absorption of headline risk. With stable credit spreads signaling underlying market resilience, LGND's PERFECT_STACK and GOLDEN_CROSS technicals suggest buyers are firmly in control of this idiosyncratic breakout.

Fired Signals

GOLDEN CROSSPERFECT STACKBARGAIN HUNTERDISTRIBUTION

Key Takeaways

Actionable Thesis: LGND is in a high-conviction breakout phase supported by PERFECT_STACK and GOLDEN_CROSS signals, fueled by serial analyst upgrades.
Key Risk: Broader macro contagion if geopolitical tensions finally spike credit spreads, or a failure to meet elevated expectations on August 6.
What to Watch: Price action around the $284.91 support floor and institutional positioning heading into the Q2 earnings print.

← Back to 2026-07-24 View Full LGND History →Yahoo Finance &nearr;